Invitrocue announced Board Changes


January 9, 2019 – Invitrocue Limited (ASX : IVQ), a leading healthcare bio-analytic solutions provider, announces the appointment of Dr. Steven Fang as Chairman of the Company’s Board of Directors with immediate effect. Dr. Fang is a co-founder and the Executive Director of Invitrocue with more than 20 years’ experience in leading and building successful healthcare companies.

As part of the planned changes to the Board as the company transitions from one focused on the development of its Onco-PDO® technology to a phase of commercial acceleration, Ms Jamie Khoo Gee Choo and Mr Koh Chow Yee have stepped down from their positions as Chairman and Director respectively. Ms Jamie Khoo will remain as the company’s non-executive director while Mr Koh will remain as company secretary.

Please click below to read full announcement.

Click to download PDF.